Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNS020QD in Patients With Chronic Pain
NCT01493245Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2011
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in chronic pain, sponsored by Janssen Pharmaceutical. Started Oct 2011; status: completed.
02
Drugs
fentanyl
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01493245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493245.